JIPYONG LLC

[Notice]Jipyong Capital Markets Group Publishes 'Jipyong IPO Practice Research (2025)'

[Notice]Jipyong Opens Continued Listing Advisory Center for Listed Companies

Jipyong Launches Global Risk Response Center

Jipyong Expands and Restructures its Management & Shareholder Disputes Center

Jipyong and Jipyong IP Sign MOU with Xlife Sciences and Co-Host NASDAQ Listing Seminar for Pharmaceutical and Biotech Companies

2023 in Review & 2024 Outlook by Practice Chairs